Drug intelligence / Profile preview

701跌打镇痛膏

Development stage
Unknown
Lead developer
Baiyunshan Hejigong Pharmaceutical Factory
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

701跌打镇痛膏 (701 Pain Relieving Plaster) is a traditional Chinese medicine (TCM) medicated plaster developed and manufactured by Guangzhou Baiyunshan Hejigong Pharmaceutical. It is formulated with a blend of active ingredients including camphor, menthol, methyl salicylate, borneol, and various herbal extracts (such as Scutellaria baicalensis, Phellodendron chinense, Reynoutria japonica, and Eupolyphaga sinensis). The plaster is designed for topical application to provide temporary relief from minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises, and sprains. It works by promoting blood circulation, dispersing blood stasis, reducing swelling, and expelling wind and dampness. The product is manufactured using a patented calendering process that allows for a high concentration of active herbal ingredients on an elastic cloth backing.

Brand names
701701 Dieda Zhentong Yaogao701 Medicated Plaster701 Pain Relieving Plaster701 Plaster for Bruise & Analgesic701跌打镇痛膏
Other names
Diedazhengtonggao Medicated Plaster跌打镇痛膏

Beyond the preview

Go deeper on 701跌打镇痛膏.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 701跌打镇痛膏.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call